NewsASCO: New hope for immunotherapy in advanced ovarian cancerAuthor:Patrice WendlngPublish date: June 9, 2015 Key clinical point: The monoclonal antibodies avelumab and pembrolizumab produced good antitumor activity in patients with advanced ovarian cancer...Read More
